• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

settlement

  1. Allergan to pay $700 million to Teva

    Allergan agrees to pay $700 million to Teva in this quarter. Teva discloses this in an SEC filing.
    • anonymous
    • Thread
    • agreement allergan arbitration settlement teva teva pharmaceuticals
    • Replies: 1
    • Forum: Allergan

  2. Thalomid - Confidential settlement with Lannett

    http://alph.st/b9f74234 Remember, Celgene settled a lawsuit for the fraudulent use of Thalomid in July 2017 for $280 million. Now Lannett is going to manufacture the generic version of Thalomid.
    • anonymous
    • Thread
    • agreement cancer treatment celgene lannett settlement
    • Replies: 0
    • Forum: Celgene

  3. Settles with Pfizer's subsidiary on Restasis patent

    Allergan reaches a settlement with InnoPharma, a subsidiary of Pfizer on Restasis patent. Out of the four contestants, Mylan, Teva and Akorn are still contesting the patents in the federal court. http://alph.st/b3437240
    • anonymous
    • Thread
    • agreement allergan lawsuit patent pfizer settlement
    • Replies: 2
    • Forum: Allergan

  4. Cialis drug's "erectile dysfunction"

    Cialis, a drug that is used to treat impotence, was given for a free trial for the first time users in 2004. Now the patent for Cialis expires earlier than the previous date.
Top Bottom
Back